Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1387.00
7.00
(0.51%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr Reddy’s Laboratories launches Ropinirole Hydrochloride XR tablets
>>
Dr. Reddy’s Laboratories enters into collaboration with Merck Serono
>>
Dr Reddys Laboratories allots equity share under ESOP
>>
Dr Reddys rises on launching OTC Lansoprazole delayed release capsules
>>
Dr Reddys Laboratories launches OTC Lansoprazole delayed release capsules
>>
Dr Reddy launches Clopidogrel Tablets
>>
Dr Reddy’s Laboratories plunges on reporting below estimates QFY12 numbers
>>
Dr Reddy’s Lab FY12 consolidated net profit rises by 29%
>>
Dr Reddy’s Lab shines on getting USFDA’s approval for ibandronate sodium tablets
>>
Dr Reddy’s Lab gets USFDA’s approval for ibandronate sodium tablets
<<
<
137
138
139
...145
>
>>